Date: 24/09/2026 17:46:36
From: buffy
ID: 2433143
Subject: re: Chat September 2026

Ian said:


Had a busy couple of days.. 3 trips to Grafton in 2 days for multiple appointments. I feel like I’ve been in a fight… and lost.

I fell heavily when down setting all the fires on Sunday.. thought I might have broken my nose..

A bloke jumped on me and twisted me one way and another yesterday.. chiro..

And the other night my GP rings me up and says he wants to do a PSA (useless bloody test) to conclude a whole battery of tests and reviews he is running before he leaves altogether.. was supposed to be gone a few weeks ago.. (I think he must have some spare time and is accumulating all the medibank items he can) ..anyway he’s still here making me go though redundant tests.. bastard says ‘Oh you’re eligible for the RSV vaccine.. you can get it now’..

Bastard! That shot hurts a lot and now I’m suffering the side effects…

Injection site reactions: Pain, redness, swelling, or tenderness where you received the shot.
General discomfort: Fatigue, tiredness, headache, or mild fever.
Body aches: Muscle or joint pain.
Stomach symptoms: Nausea or diarrhea.

Talk about brainless meat-sacks!

Here is the latest (this year) update from Cochrane on the usefulness of PSA testing. Some ifs/but/maybes in that.

Link to report telling you how they did it

>>Summary: Screening likely reduces prostate cancer‐specific mortality and may reduce overall mortality. It may have little to no effect on adverse events (as measured by intervention‐related mortality). Study limitations, inconsistency, and imprecision reduced our confidence in the effect estimates. Interpretation of these findings is highly sensitive to the choice of MCID. We found insufficient evidence on the potential harms of screening, such as biopsy‐ and treatment‐related complications. Emerging alternatives, such as screening with a kallikrein panel and MRI, may have little to no effect on diagnoses of prostate cancer, but the results on mortality are not yet known. <<

Reply Quote View full thread